Trump budget would limit NIH grant recipients' spending on admin, IT

A cap could be placed on what “indirect” medical research costs can be covered by National Institutes of Health (NIH) grants, which researchers warn could “disembowel” their institutions.

As reported by The Atlantic, the Trump administration’s full budget, due out next week, could include a 10 percent cap on overhead costs like administration, equipment, libraries, IT, lighting, heating, electricity. HHS Secretary Tom Price, MD, has said such costs are evidence of “inefficiencies” in NIH, with some universities spending up to 85 percent of their grants on those costs, which are negotiated with the agency.

Those in the research field, however, say many of the costs aren’t optional and grants don’t always fund what it takes to keep labs and research facilities running.

“We could find efficiencies,” said Mary Woolley, president of Research!America, a non-profit that advocates for biomedical research, “but you’re not looking for efficiencies when you say we’ll cut off three or four of your appendages.”

Read the full article at the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

"The number of non-facility services reimbursed at less than direct costs grew 50% since 2024. The number of services under the MPFS for which reimbursement does not even cover cost likely is much higher than 300 services," the proposed AMA resolution states.

COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.

Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.